Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Verastem, Inc. Director's Dealing 2024

Mar 13, 2024

32713_dirs_2024-03-13_ff385d07-fd53-4226-b0f6-27a4b441dfd3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verastem, Inc. (VSTM)
CIK: 0001526119
Period of Report: 2024-03-11

Reporting Person: Stuglik Brian M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-11 Stock Option (right to buy) $59.04 D 4166 Disposed 2028-06-11 Common Stock (2157) Direct
2024-03-11 Stock Option (right to buy) $21.72 D 7699 Disposed 2029-06-21 Common Stock (2083) Direct
2024-03-11 Stock Option (right to buy) $11.44 A 11865 Acquired 2034-03-11 Common Stock (11865) Direct

Footnotes

F1: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on October 2, 2017 ending on September 2, 2018.

F3: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.